a, b and c denote oligo-barcodes modified with red and green colours by biotin-dUTP and digoxigenin-dUTP antibodies respectively. Based on the mapping results of cytogenetic markers, we illustrated ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

Jobs in one particular industry are projected to grow much faster than the average of all occupations, according to the ...

In a discussion with Peers & Perspectives in Oncology, fellowship program director Marc J. Braunstein, MD, PhD, FACP, and ...

It seemed to improve MRD negativity rates across all the different subgroups, so, despite age, race, ISS stage, their response at diagnosis, and the different risk classifications for cytogenetic ...

During a Case-Based Roundtable® event, Hira Shaikh, MD, and participants discussed how they would treat a patient with ...

Geron (GERN) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a ...

The European Medicines Agency (EMA) has given a positive recommendation for Rytelo ( imetelstat) for the treatment of adult ...

Umbilical cord blood transplant has been successfully performed for CML patients in accelerated phase or blastic transformation. [87,88,89] The utility of cord blood transplants for adult ...

SAN DIEGO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that on December 19, 2024, it published an open letter to stockholders in support of its proposals at its ...

A significant overall survival (OS) benefit with belantamab mafodotin (belantamab; Blenrep) in a phase III trial of relapsed ...